Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alaa Alghamry

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Pain Physician|November 18, 2021
Using L1 CT Attenuation to Predict Fracture RiskJoseph Lee, Alaa Alghamry
The New England Journal of Medicine|July 9, 2020
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve ReplacementAlaa Alghamry, Dale J Murdoch
Osteoporosis and Sarcopenia|October 21, 2022
Significant change for body composition dataJoseph C Lee, Alaa Alghamry
Bone|April 17, 2021
Significant change in serial BMD studiesJoseph C Lee, Alaa Alghamry
The Medical Journal of Australia|February 10, 2022
The ABCD of the comprehensive geriatric assessmentAlaa Alghamry, Joseph C Lee
Journal of Echocardiography|January 20, 2022
Variability in echocardiography interpretationJoseph C Lee, Alaa Alghamry
Nuclear Medicine Review. Central & Eastern Europe|August 5, 2022
Multiple benefits of added computed tomography for myocardial perfusion imaging in patients with psoriasisJoseph C Lee, Alaa Alghamry
Bone|May 3, 2021
Utilising DXA for body composition research studiesJoseph C Lee, Alaa Alghamry
Anatolian Journal of Cardiology|July 8, 2021
Cerebrovascular ischemic event - what about the coronariesJoseph C Lee, Alaa Alghamry
The New England Journal of Medicine|March 11, 2021
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral ValveAlaa Alghamry, Joseph C Lee
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Pain Physician|November 18, 2021
Using L1 CT Attenuation to Predict Fracture RiskJoseph Lee, Alaa Alghamry
The New England Journal of Medicine|July 9, 2020
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve ReplacementAlaa Alghamry, Dale J Murdoch
Osteoporosis and Sarcopenia|October 21, 2022
Significant change for body composition dataJoseph C Lee, Alaa Alghamry
Bone|April 17, 2021
Significant change in serial BMD studiesJoseph C Lee, Alaa Alghamry
The Medical Journal of Australia|February 10, 2022
The ABCD of the comprehensive geriatric assessmentAlaa Alghamry, Joseph C Lee
Journal of Echocardiography|January 20, 2022
Variability in echocardiography interpretationJoseph C Lee, Alaa Alghamry
Nuclear Medicine Review. Central & Eastern Europe|August 5, 2022
Multiple benefits of added computed tomography for myocardial perfusion imaging in patients with psoriasisJoseph C Lee, Alaa Alghamry
Bone|May 3, 2021
Utilising DXA for body composition research studiesJoseph C Lee, Alaa Alghamry
Anatolian Journal of Cardiology|July 8, 2021
Cerebrovascular ischemic event - what about the coronariesJoseph C Lee, Alaa Alghamry
The New England Journal of Medicine|March 11, 2021
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral ValveAlaa Alghamry, Joseph C Lee
Pageof 3